Role of a Janus kinase 2-dependent signaling pathway in platelet activation

2014 ◽  
Vol 133 (6) ◽  
pp. 1088-1096 ◽  
Author(s):  
Wan-Jung Lu ◽  
Kao-Chang Lin ◽  
Shih-Yi Huang ◽  
Philip Aloysius Thomas ◽  
Yu-Hua Wu ◽  
...  
2001 ◽  
Vol 31 (11) ◽  
pp. 1159
Author(s):  
Hainan Piao ◽  
Jin Sook Kwon ◽  
Hye Young Lee ◽  
Tae Jin Youn ◽  
Dong Woon Kim ◽  
...  

2020 ◽  
Vol 21 (23) ◽  
pp. 9004
Author(s):  
Alexandra Damerau ◽  
Timo Gaber ◽  
Sarah Ohrndorf ◽  
Paula Hoff

The Janus kinase (JAK) signal transducer and activator of transcription (STAT) signaling pathway serves as an important downstream mediator for a variety of cytokines, hormones, and growth factors. Emerging evidence suggests JAK/STAT signaling pathway plays an important role in bone development, metabolism, and healing. In this light, pro-inflammatory cytokines are now clearly implicated in these processes as they can perturb normal bone remodeling through their action on osteoclasts and osteoblasts at both intra- and extra-articular skeletal sites. Here, we summarize the role of JAK/STAT pathway on development, homeostasis, and regeneration based on skeletal phenotype of individual JAK and STAT gene knockout models and selective inhibition of components of the JAK/STAT signaling including influences of JAK inhibition in osteoclasts, osteoblasts, and osteocytes.


2019 ◽  
Vol 9 (1) ◽  
Author(s):  
Na-Young Park ◽  
In Hwang Kim ◽  
Yancheng Wen ◽  
Keun-Woo Lee ◽  
Sora Lee ◽  
...  

AbstractLeuO plays the role of a master regulator in the cyclic-L-phenylalanine-L-proline (cFP)-dependent signaling pathway in Vibrio vulnificus. cFP, as shown through isothermal titration calorimetry analysis, binds specifically to the periplasmic domain of ToxR. Binding of cFP triggers a change in the cytoplasmic domain of ToxR, which then activates transcription of leuO encoding a LysR-type regulator. LeuO binds to the region upstream of its own coding sequence, inhibiting its own transcription and maintaining a controlled level of expression. A five-bp deletion in this region abolished expression of LeuO, but a ten-bp deletion did not, suggesting that a DNA bending mechanism is involved in the regulation. Furthermore, binding of RNA polymerase was significantly lower both in the deletion of the ToxR binding site and in the five-bp deletion, but not in the ten-bp deletion, as shown in pull-down assays using an antibody against RNA polymerase subunit α. In summary, multiple factors are involved in control of the expression of LeuO, a master regulator that orchestrates downstream regulators to modulate factors required for survival and pathogenicity of the pathogen.


2001 ◽  
Vol 276 (21) ◽  
pp. 17815-17822 ◽  
Author(s):  
Heather E. Tibbles ◽  
Alexei Vassilev ◽  
Heather Wendorf ◽  
Dawn Schonhoff ◽  
Dan Zhu ◽  
...  

2016 ◽  
Vol 14 (1) ◽  
pp. 797-803 ◽  
Author(s):  
XIANG YANG CHENG ◽  
XIAO YU GU ◽  
QIN GAO ◽  
QIAO FENG ZONG ◽  
XIAO HONG LI ◽  
...  

1999 ◽  
Vol 10 (11) ◽  
pp. 3959-3970 ◽  
Author(s):  
Rui Liu ◽  
Tohru Itoh ◽  
Ken-ichi Arai ◽  
Sumiko Watanabe

Human granulocyte-macrophage colony-stimulating factor (hGM-CSF) induces proliferation and sustains the viability of the mouse interleukin-3-dependent cell line BA/F3 expressing the hGM-CSF receptor. Analysis of the antiapoptosis activity of GM-CSF receptor βc mutants showed that box1 but not the C-terminal region containing tyrosine residues is essential for GM-CSF-dependent antiapoptotic activity. Because βc mutants, which activate Janus kinase 2 but neither signal transducer and activator of transcription 5 nor the MAPK cascade sustain antiapoptosis activity, involvement of Janus kinase 2, excluding the above molecules, in antiapoptosis activity seems likely. GM-CSF activates phosphoinositide-3-OH kinase as well as Akt, and activation of both was suppressed by addition of wortmannin. Interestingly, wortmannin did not affect GM-CSF-dependent antiapoptosis, thus indicating that the phosphoinositide-3-OH kinase pathway is not essential for cell surivival. Analysis using the tyrosine kinase inhibitor genistein and a MAPK/extracellular signal-regulated kinase (ERK) kinase 1 inhibitor, PD98059, indicates that activation of either the genistein-sensitive signaling pathway or the PD98059-sensitive signaling pathway from βc may be sufficient to suppress apoptosis. Wild-type and a βc mutant lacking tyrosine residues can induce expression of c-myc andbcl-xLgenes; however, drug sensitivities for activation of these genes differ from those for antiapoptosis activity of GM-CSF, which means that these gene products may be involved yet are inadequate to promote cell survival.


FEBS Letters ◽  
2001 ◽  
Vol 511 (1-3) ◽  
pp. 15-20 ◽  
Author(s):  
Kaoru Sakabe ◽  
Hidemi Teramoto ◽  
Muriel Zohar ◽  
Babak Behbahani ◽  
Hiroshi Miyazaki ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document